Articles dans des revues avec comité de lecture (167)
  1. 68. Lugassy, C., Torres-Muñoz, J. E., Kleinman, H. K., Ghanem, G. E., Vernon, S., & Barnhill, R. L. (2009). Overexpression of malignancy-associated laminins and laminin receptors by angiotropic human melanoma cells in a chick chorioallantoic membrane model. Journal of cutaneous pathology, 36(12), 1237-1243. doi:10.1111/j.1600-0560.2009.01273.x
  2. 69. Vereecken, P., Awada, A., Suciu, S., Castro, G., Morandini, R., Litynska, A., Lienard, D., Ezzedine, K. K., Ghanem, G. E., & Heenen, M. (2009). Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients. Melanoma research, 19(5), 316-320. doi:10.1097/CMR.0b013e32832ec001
  3. 70. Dierickx, K. M. E., Journé, F., Gerbaux, P., Morandini, R., Kauffmann, J.-M., & Ghanem, G. E. (2009). Improving the spectrophotometric determination of the alkylating activity of anticancer agents: a new insight into the mechanism of the NBP method. Talanta, 77(4), 1370-1375. doi:10.1016/j.talanta.2008.09.015
  4. 71. Dessars, B., De Raeve, L., Morandini, R., Lefort, A., El Housni, H., Ghanem, G. E., Van den Eynde, B. J., Ma, W., Roseeuw, D., Vassart, G., Libert, F., & Heimann, P. (2009). Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis. Journal of investigative dermatology, 129(1), 139-147. doi:10.1038/jid.2008.203
  5. 72. Flamen, P., Vanderlinden, B., Delatte, P., Ghanem, G. E., Ameye, L., Van Den Eynde, M., & Hendlisz, A. (2008). Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres. Physics in medicine and biology, 53(22), 6591-6603. doi:10.1088/0031-9155/53/22/019
  6. 73. Dierickx, K. M. E., Morandini, R., Nguyen, T. H., Sales, F., Kauffmann, J.-M., & Ghanem, G. E. (2008). A novel transport and delivery mechanism underpins the effectiveness of prolyl-m-sarcolysyl-p-fluorophenylalanine (PSF) in a human melanoma xenograft nude-mouse model. Pigment Cell & Melanoma Research, 21(4), 439-450. doi:10.1111/j.1755-148X.2008.00471.x
  7. 74. Dessars, B., De Raeve, L., El Housni, H., Debouck, C., Sidon, P., Morandini, R., Roseeuw, D., Ghanem, G. E., Vassart, G., & Heimann, P. (2007). Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi. Journal of investigative dermatology, 127(6), 1468-1470. doi:10.1038/sj.jid.5700725
  8. 75. Vereecken, P., Awada, A., Ghanem, G. E., Marques Da Costa, C., Larsimont, D., Simoens, C., Mendes da Costa, P., & Hendlisz, A. (2007). A therapeutic approach to perianal extramammary Paget's disease: topical imiquimod can be useful to prevent or defer surgery. Medical Science Monitor, 13(6), CS75-CS77.
  9. 76. Vereecken, P., Awada, A., Ghanem, G. E., Marques Da Costa, C., Larsimont, D., Simoens, C., Mendes Da Costa, P., & Hendlisz, A. (2007). A Therapeutic approach to perianal extramammary Paget’s disease: Tropical imiquimod can be useful to prevent or defer surgery. Medical Science Monitor, 13(6), 75-77.
  10. 77. Solano, F., Briganti, S., Picardo, M., & Ghanem, G. E. (2006). Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment cell research, 19(6), 550-571. doi:10.1111/j.1600-0749.2006.00334.x
  11. 78. Pedeux, R., Sales, F., Pourchet, J., Kallassy, M., Fayolle, C., Boniol, M., Severi, G., Ghanem, G. E., Nakazawa, H. N., Autier, P., & Doré, J.-F. (2006). Ultraviolet B sensitivity of peripheral lymphocytes as an independent risk factor for cutaneous melanoma. European journal of cancer, 42(2), 212-215. doi:10.1016/j.ejca.2005.09.021
  12. 79. Suciu, S., Ghanem, G. E., & Eggermont, A. (2006). Serum S100B protein evaluation in an EORTC randomized melanoma trial: A first report. Oncología, 29(1), 75-78.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Suivant >>